Solid Biosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-2.16-2.30-1.97-5.82
Price/Sales ratio
169.64344.3114.213.88
Earnings per Share (EPS)
$-2.70$-2.54$-2.96$-1.00

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-68.22-20.19-13.98-11.91-1.55-4.36-2.59-0.69-1.27-0.30-6.73
Price/Sales ratio
N/AN/AN/AN/AN/AN/A13.715.65N/A2.53N/A
Price/Book Value ratio
-6.44-5.15-12.307.122.232.980.890.210.960.192.61
Price/Cash Flow ratio
-103.48-21.62-16.86-12.69-1.93-6.95-2.40-0.46-1.29-0.29-7.31
Price/Free Cash Flow ratio
-103.48-21.20-16.02-11.43-1.84-6.84-2.36-0.45-1.27-0.28-6.63
Price/Earnings Growth ratio
N/A-0.08-0.31-0.30-0.050.110.040.020.03-1.170.02
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A-331.27%70.24%N/A38.10%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A-530.49%-1315.19%N/A-971.12%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A-530.01%-1062.28%N/A-842.60%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A-529.54%-809.36%N/A-842.60%N/A
Effective Tax Rate
4.30%10.94%2.40%-1.18%1.34%-2.07%0.08%23.80%N/AN/A-0.36%
Return on Assets
-11.44%-53.00%-68.40%-53.58%-111.76%-52.64%-31.03%-25.17%-58.21%-52.41%-82.67%
Return On Equity
9.44%25.53%87.95%-59.75%-144.46%-68.22%-34.63%-30.94%-75.91%-77.64%-111.05%
Return on Capital Employed
-15.71%-75.75%-84.49%-59.54%-140.05%-60.26%-34.60%-44.77%-69.34%-66.12%-99.79%
Liquidity Ratios
Current Ratio
N/AN/A6.2610.304.726.49N/AN/AN/A9.757.51
Quick Ratio
45.816.2610.304.726.499.179.758.939.497.51
Cash ratio
2.051.114.626.914.166.325.046.905.096.905.54
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A2.94N/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A37.37N/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A40.32N/AN/AN/AN/A
Days of Payables Outstanding
N/A19.44K4.12K860.29920.77304.6927.73490.809.68N/A612.73
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A12.59-490.80N/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/A0.000.060.030.000.100.010.180.03
Debt Equity Ratio
N/AN/AN/A0.000.080.030.000.130.010.220.04
Long-term Debt to Capitalization
N/AN/AN/A0.000.060.020.000.10N/A0.100.03
Total Debt to Capitalization
N/AN/AN/A0.000.080.030.000.110.010.110.04
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/A-68.02-13.11-10.98-37.69-3.43-40.52-4.94-40.56
Company Equity Multiplier
-0.82-0.48-1.281.111.291.291.111.221.301.221.29
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A-5.70-12.10N/A-8.71N/A
Free Cash Flow / Operating Cash Flow Ratio
11.011.051.111.041.011.011.031.011.031.03
Cash Flow Coverage Ratio
N/AN/AN/A-68.02-13.11-10.98-37.69-3.43-40.52-4.94-40.56
Short Term Coverage Ratio
N/AN/AN/A-405.76-48.23-25.64-52.01-38.19-40.52-54.98-36.94
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A